Patents by Inventor Christelle Faveeuw

Christelle Faveeuw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ACTIVATION OF iNKT CELLS
    Publication number: 20200230164
    Abstract: The present invention relates to particulate entity, such as a nanoparticle or conjugate, for use in particular as adjuvant in vaccine or immunotherapy. More specifically, the invention relates to a particulate entity comprising: iv. an iNKT cell agonist such as ? Gal Car compound, and, v. one or more antigenic determinant(s) such as a tumour antigen(s) or pathogen-derived antigen(s), vi. a targeting agent that targets in vivo said iNKT cell agonist to dendritic cells, such as human BDCA3-dendritic cells.
    Type: Application
    Filed: January 24, 2020
    Publication date: July 23, 2020
    Inventors: Francois TROTTEIN, Christelle FAVEEUW, Elodie MACHO FERNANDEZ, Luis Javier CRUZ RICONDO
  • ACTIVATION OF iNKT CELLS
    Publication number: 20150374734
    Abstract: The present invention relates to particulate entity, such as a nanoparticle or conjugate, for use in particular as adjuvant in vaccine or immunotherapy. More specifically, the invention relates to a particulate entity comprising: iv. an iNKT cell agonist such as ? Gal Car compound, and, v. one or more antigenic determinant(s) such as a tumour antigen(s) or pathogen-derived antigen(s), vi. a targeting agent that targets in vivo said iNKT cell agonist to dendritic cells, such as human BDCA3+ dendritic cells.
    Type: Application
    Filed: February 20, 2014
    Publication date: December 31, 2015
    Inventors: Francois TROTTEIN, Christelle FAVEEUW, Elodie MACHO FERNANDEZ, Luis Javier CRUZ RICONDO
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA
    Publication number: 20150246095
    Abstract: The present invention relates to methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza. In particular, the present invention relates to an interleukin 22 (IL-22) polypeptide for use in the prophylactic treatment of bacterial superinfections post-influenza in a subject in need thereof.
    Type: Application
    Filed: October 1, 2013
    Publication date: September 3, 2015
    Inventors: Francois Trottein, Stoyan Ivanov, Josette Fontaine, Christelle Faveeuw
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE PROPHYLACTIC TREATMENT OF BACTERIAL SUPERINFECTIONS POST-INFLUENZA WITH INVARIANT NKT CELL AGONISTS
    Publication number: 20150224129
    Abstract: The present invention relates to methods and pharmaceutical compositions for the prophylactic treatment of bacterial superinfections post-influenza with iNKT cell agonists.
    Type: Application
    Filed: October 1, 2013
    Publication date: August 13, 2015
    Applicants: INSERM (Institut National de la Santé et de la Recherche Médicale), INSTITUT PASTEUR DE LILLE, UNIVERSITÉ DE LILLE 1 - SCIENCES ET TECHNOLOGIES, UNIVERSITÉ DU DROIT ET DE LA SANTÉ LILLE 2, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)
    Inventors: Francois Trottein, Christelle Faveeuw, Stoyan Ivanov, Josette Fontaine